Telo Genomics Corp.
TDSGF
$0.03
$0.003.57%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.70% | 3.97% | 23.00% | 13.26% | -34.21% |
| Total Depreciation and Amortization | 47.55% | 615.00% | -4.76% | 5.00% | -13.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -45.76% | -- |
| Change in Net Operating Assets | -53.50% | 21.56% | 85.03% | 135.92% | -277.68% |
| Cash from Operations | -52.91% | 29.87% | 34.25% | 52.16% | -139.39% |
| Capital Expenditure | 100.00% | -700.00% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -10,560.00% | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 99.77% |
| Cash from Financing | -- | -- | -- | 100.00% | -100.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 312.59% | -42.40% | 33.80% | 52.34% | -150.78% |